Correlation Between Senti Biosciences and Monopar Therapeutics
Can any of the company-specific risk be diversified away by investing in both Senti Biosciences and Monopar Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Senti Biosciences and Monopar Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Senti Biosciences and Monopar Therapeutics, you can compare the effects of market volatilities on Senti Biosciences and Monopar Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Senti Biosciences with a short position of Monopar Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Senti Biosciences and Monopar Therapeutics.
Diversification Opportunities for Senti Biosciences and Monopar Therapeutics
0.09 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Senti and Monopar is 0.09. Overlapping area represents the amount of risk that can be diversified away by holding Senti Biosciences and Monopar Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Monopar Therapeutics and Senti Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Senti Biosciences are associated (or correlated) with Monopar Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Monopar Therapeutics has no effect on the direction of Senti Biosciences i.e., Senti Biosciences and Monopar Therapeutics go up and down completely randomly.
Pair Corralation between Senti Biosciences and Monopar Therapeutics
Given the investment horizon of 90 days Senti Biosciences is expected to under-perform the Monopar Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Senti Biosciences is 1.48 times less risky than Monopar Therapeutics. The stock trades about -0.12 of its potential returns per unit of risk. The Monopar Therapeutics is currently generating about 0.08 of returns per unit of risk over similar time horizon. If you would invest 3,352 in Monopar Therapeutics on November 27, 2024 and sell it today you would earn a total of 247.00 from holding Monopar Therapeutics or generate 7.37% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Senti Biosciences vs. Monopar Therapeutics
Performance |
| Timeline |
| Senti Biosciences |
| Monopar Therapeutics |
Senti Biosciences and Monopar Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Senti Biosciences and Monopar Therapeutics
The main advantage of trading using opposite Senti Biosciences and Monopar Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Senti Biosciences position performs unexpectedly, Monopar Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Monopar Therapeutics will offset losses from the drop in Monopar Therapeutics' long position.| Senti Biosciences vs. Cadrenal Therapeutics, Common | Senti Biosciences vs. Foghorn Therapeutics | Senti Biosciences vs. Quoin Pharmaceuticals Ltd | Senti Biosciences vs. SAB Biotherapeutics |
| Monopar Therapeutics vs. Anebulo Pharmaceuticals | Monopar Therapeutics vs. Acrivon Therapeutics, Common | Monopar Therapeutics vs. Pmv Pharmaceuticals | Monopar Therapeutics vs. Molecular Partners AG |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Other Complementary Tools
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Stocks Directory Find actively traded stocks across global markets |